Pia Davidsson - Concepedia

Author

Pia Davidsson

Sahlgrenska University Hospital ORCID

Also Known As

De 560 Brger, P Davidsson, P. Davidsson, Pia Davidsson

139

Publications

10.7K

Citations

H-Index

114

Concepts

All Affiliations

Sahlgrenska University Hospital University of Gothenburg AstraZeneca (Sweden)Karolinska Institutet Fujirebio (Belgium)

About

Pia Davidsson is an author at Sahlgrenska University Hospital specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	48	4.3K
2	Social Sciences	11	11	997
3	Natural Sciences	10	10	419
4	Health Sciences	5	5	410
5	Public Health	2	2	37

Pia Davidsson

101

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease Niels Andreasen, Camilla Hesse, Pia Davidsson, Archives of Neurology	1999	658
Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice Niels Andreasen, Lennart Minthon, Pia Davidsson, Archives of Neurology	2001	570
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization Eugeen Vanmechelen, Hugo Vanderstichele, Pia Davidsson, Neuroscience Letters AllergyMedicinePharmacologyHuman Cerebrospinal FluidSandwich Elisa	2000	488
Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values Magnus Sjögren, Hugo Vanderstichele, Hans Ågren, Clinical Chemistry	2001	436
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke Camilla Hesse, Lars Rosengren, Niels Andreasen, Neuroscience Letters Transient IncreaseTotal TauIschemic StrokeNeurophysiologyMedicine	2001	435
Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples Karin Björhall, Tasso Miliotis, Pia Davidsson PROTEOMICS	2005	385
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease Maja Puchades, Sara Hansson, Carol L. Nilsson, Molecular Brain Research Proteomic TechnologyAlzheimer's DiseaseMedicineDementiaProteomic Studies	2003	305
Standardization of measurement of β-amyloid<sub>(1-42)</sub>in cerebrospinal fluid and plasma Hugo Vanderstichele, E Van Kerschaver, Camilla Hesse, Amyloid	2000	304
CSF levels of tau, β-amyloid 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging Magnus Sjögren, Lennart Minthon, Pia Davidsson, Journal of Neural Transmission Csf LevelsNeurodegenerative DiseasesAgingDementiaOther Types	2000	245
Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment Nancy C. Andreasen, Lennart Minthon, Eugeen Vanmechelen, Neuroscience Letters Neurodegenerative DiseasesCerebrospinal Fluid TauAlzheimer's DiseaseBrain DevelopmentNeurochemical Biomarkers	1999	241

Page 1